Dr. Aldo Iacono, Medical Director of Lung Transplantation, led a successful study using inhaled cyclosporine for prevention of lung transplant rejection, the results of which were published in the Jan. 12, 2006 edition of the New England Journal of Medicine.
Dr. Steven Liggett moves to Maryland. Dr. Steven Liggett, a world-renowned expert in genomics of asthma and heart failure and G-protein coupled receptors has moved his program to the University of Maryland School of Medicine Division of Pulmonary and Critical Care Medicine.
Dr. Aldo Iacono is named Medical Director of Lung Transplantation. Dr. Aldo Iacono has moved from University of Pittsburgh to join Dr. Bart Griffith as Medical Director of Lung Transplantion. Dr. Iacono is an expert in the pretransplant evaluation and perioperative and postoperative management of lung transplant patients. His clinical research focuses on new methods for monitoring and treating rejection and he led a successful study using inhaled cyclosporine for prevention of lung transplant rejection. With Dr. Iacono's arrival, the fellowship curriculum was expanded to include a lung transplant rotation.
State-of-the-art 29-bed MICU to open May, 2006.
The new 29-bed Medical Intensive Care Unit located on the seventh floor of the new Harry and Jeannette Weinberg Building is scheduled to open in May, 2006. This facility will combine cutting-edge technology with a pleasant, comfortable environment for staff, patients, and their families. The MICU is located in the same building with the Emergency Department, the Operating Room, and Radiology services.
The Inflammation Research Group reaches milestone.
The Inflammation Research Group is a working group of laboratories from the University of Maryland, Baltimore, University of Maryland, College Park, the NIH, and Johns Hopkins University. The group meets weekly to exchange ideas about mechanisms of inflammation across disciplines, developnew ideas about inflammation, and form new collaborations including those between basic and clinical researchers. The group has reached a new milestone with the addition of its 50th member laboratory.
The University of Maryland is named a site in COPD Clinical Research Network.
The Division of Pulmonary and Critical Care Medicine at the University of Maryland has been awarded a contract to serve as one of the founding members of the NHLBI-funded COPD Clinical Research Network. The University's center, directed by Dr. Steven Scharf joins other prestigious institutions including, Brigham and Women's Hospital in Boston, the University of Alabama at Birmingham, the University of Colorado at Denver, the University of Minnesota at Minneapolis, the University of California at Los Angeles and the University of California at San Francisco.
The University of Maryland is named a site in ARDSNet-2.
The University of Maryland and our colleagues at Johns Hopkins University were founding members of ARDSNet, an NHLBI-funded clinical research network focused on treatment for adult respiratory distress syndrome and have been awarded a contract to provide a Baltimore site for ARDSNet-2. The University of Maryland site will be directed by Dr. Carl Shanholtz, Director of the University of Maryland Medical Center MICU.
The University of Maryland is awarded K12 award.
The University of Maryland School of Medicine was awarded a K12 institutional career development award. In September 2005, the University of Maryland was awarded a Multidisciplinary Clinical Research Career Development Program (Roadmap K12 Program), one of a handful of such programs in the nation. The overall aim of the Multidisciplinary Clinical Research Career Development Program is to support the early career development of clinical researchers - known as NIH Clinical Research Scholars (CR Scholars) - in all types of clinical research, including patient-oriented research, translational research, small- and large-scale clinical investigation and trials, and epidemiologic and natural history.
Pulmonary and Critical Care Medicine Fellowship expands.
Based on the expanding MICU and lung transplantation services and the dramatic increase in research training opportunities, the University of Maryland Division of Pulmonary Medicine has expanded its three-year fellowship training program to a total of 12 fellows. The Division continues to support research training beyond the three-year program for individuals pursuing academic careers.
University of Maryland Pulmonary and Critical Care Fellows continue 100% pass rate on boards.
The pass rate for University of Maryland pulmonary and critical care fellows taking pulmonary and critical care boards in 2004 was once again 100%, maintaining a long-running tradition in the division.
University of Maryland Pulmonary and Critical Care Fellows score 100% on ATS submissions.
All second and third year pulmonary and critical care fellows have submitted research abstracts for the 2006 international American Thoracic Society meeting, reflecting the hard work by the fellows and their mentors.
Pulmonary and Critical Care faculty continue international activities.